101 related articles for article (PubMed ID: 12530058)
1. Down's syndrome-associated single minded gene as a novel tumor marker.
Deyoung MP; Scheurle D; Damania H; Zylberberg C; Narayanan R
Anticancer Res; 2002; 22(6A):3149-57. PubMed ID: 12530058
[TBL] [Abstract][Full Text] [Related]
2. Identification of Down's syndrome critical locus gene SIM2-s as a drug therapy target for solid tumors.
DeYoung MP; Tress M; Narayanan R
Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4760-5. PubMed ID: 12676991
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of SIM2-s protein is a novel marker of aggressive prostate cancer.
Halvorsen OJ; Rostad K; Øyan AM; Puntervoll H; Bø TH; Stordrange L; Olsen S; Haukaas SA; Hood L; Jonassen I; Kalland KH; Akslen LA
Clin Cancer Res; 2007 Feb; 13(3):892-7. PubMed ID: 17289882
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Single Minded 2 gene expression mediates tumor-selective apoptosis and differentiation in human colon cancer cells.
Aleman MJ; DeYoung MP; Tress M; Keating P; Perry GW; Narayanan R
Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12765-70. PubMed ID: 16129820
[TBL] [Abstract][Full Text] [Related]
5. Bioinformatics-based discovery of a novel factor with apparent specificity to colon cancer.
De Young MP; Damania H; Scheurle D; Zylberberg C; Narayanan R
In Vivo; 2002; 16(4):239-48. PubMed ID: 12224133
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics approaches to cancer gene discovery.
Narayanan R
Methods Mol Biol; 2007; 360():13-31. PubMed ID: 17172723
[TBL] [Abstract][Full Text] [Related]
7. Relevant genomics of neurotensin receptor in cancer.
Elek J; Pinzon W; Park KH; Narayanan R
Anticancer Res; 2000; 20(1A):53-8. PubMed ID: 10769634
[TBL] [Abstract][Full Text] [Related]
8. Cancer gene discovery using digital differential display.
Scheurle D; DeYoung MP; Binninger DM; Page H; Jahanzeb M; Narayanan R
Cancer Res; 2000 Aug; 60(15):4037-43. PubMed ID: 10945605
[TBL] [Abstract][Full Text] [Related]
9. NeuroD1 expression in human prostate cancer: can it contribute to neuroendocrine differentiation comprehension?
Cindolo L; Franco R; Cantile M; Schiavo G; Liguori G; Chiodini P; Salzano L; Autorino R; Di Blasi A; Falsaperla M; Feudale E; Botti G; Gallo A; Cillo C
Eur Urol; 2007 Nov; 52(5):1365-73. PubMed ID: 17126478
[TBL] [Abstract][Full Text] [Related]
10. The expression of pluripotency marker Oct 3/4 in prostate cancer and benign prostate hyperplasia.
Monsef N; Soller M; Isaksson M; Abrahamsson PA; Panagopoulos I
Prostate; 2009 Jun; 69(9):909-16. PubMed ID: 19274762
[TBL] [Abstract][Full Text] [Related]
11. Analysis of gene expression profile in colon cancer using the Cancer Genome Anatomy Project and RNA interference.
Huang ZG; Ran ZH; Lu W; Xiao SD
Chin J Dig Dis; 2006; 7(2):97-102. PubMed ID: 16643337
[TBL] [Abstract][Full Text] [Related]
12. Down's syndrome-associated Single Minded 2 gene as a pancreatic cancer drug therapy target.
DeYoung MP; Tress M; Narayanan R
Cancer Lett; 2003 Oct; 200(1):25-31. PubMed ID: 14550949
[TBL] [Abstract][Full Text] [Related]
13. The role of prostate specific membrane antigen and pepsinogen C tissue expression as an adjunctive method to prostate cancer diagnosis.
Antunes AA; Leite KR; Sousa-Canavez JM; Camara-Lopes LH; Srougi M
J Urol; 2009 Feb; 181(2):594-600. PubMed ID: 19084862
[TBL] [Abstract][Full Text] [Related]
14. Comparative gene and protein expression in primary cultures of epithelial cells from benign prostatic hyperplasia and prostate cancer.
Rose A; Xu Y; Chen Z; Fan Z; Stamey TA; McNeal JE; Caldwell M; Peehl DM
Cancer Lett; 2005 Sep; 227(2):213-22. PubMed ID: 16112424
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of PIM-1 is a potential biomarker in prostate carcinoma.
Xu Y; Zhang T; Tang H; Zhang S; Liu M; Ren D; Niu Y
J Surg Oncol; 2005 Dec; 92(4):326-30. PubMed ID: 16299799
[TBL] [Abstract][Full Text] [Related]
16. In-silico analysis of kallikrein gene expression in pancreatic and colon cancers.
Yousef GM; Borgoño CA; Popalis C; Yacoub GM; Polymeris ME; Soosaipillai A; Diamandis EP
Anticancer Res; 2004; 24(1):43-51. PubMed ID: 15015574
[TBL] [Abstract][Full Text] [Related]
17. A novel human G protein-coupled receptor is over-expressed in prostate cancer.
Parmigiani RB; Magalhães GS; Galante PA; Manzini CV; Camargo AA; Malnic B
Genet Mol Res; 2004 Dec; 3(4):521-31. PubMed ID: 15688318
[TBL] [Abstract][Full Text] [Related]
18. GCIP/CCNDBP1, a helix-loop-helix protein, suppresses tumorigenesis.
Ma W; Stafford LJ; Li D; Luo J; Li X; Ning G; Liu M
J Cell Biochem; 2007 Apr; 100(6):1376-86. PubMed ID: 17131381
[TBL] [Abstract][Full Text] [Related]
19. Type IV collagenase (matrix metalloproteinase-2 and -9) in prostate cancer.
Zhang L; Shi J; Feng J; Klocker H; Lee C; Zhang J
Prostate Cancer Prostatic Dis; 2004; 7(4):327-32. PubMed ID: 15356679
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of the human kallikrein gene 14 (KLK14) in normal and cancerous prostatic tissues.
Yousef GM; Stephan C; Scorilas A; Ellatif MA; Jung K; Kristiansen G; Jung M; Polymeris ME; Diamandis EP
Prostate; 2003 Sep; 56(4):287-92. PubMed ID: 12858357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
